Journal of Endocrinological Investigation

, Volume 19, Issue 11, pp 763–779 | Cite as

Growth hormone cotreatment with gonadotropins in ovulation induction

  • P. G. Artini
  • A. A. de Micheroux
  • G. D’Ambrogio
Review Article

Key words

Growth hormone growth hormone releasing factor insulin-like growth factors ovary ovulation induction polycystic ovaries poor responded 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sheikholislam B.M., Stempfei R.S. jr. Hereditary isolated somatotropin deficiency: effects of human growth hormone deficiency administration. Pediatrics 49: 362, 1972.PubMedGoogle Scholar
  2. 2.
    Ramaley JA, Phares C.K. Delay of puberty onset in females due to suppression of growth hormone. Endocrinology 106: 1989, 1980.PubMedGoogle Scholar
  3. 3.
    Darendeliler F., Hindmarsh P.C., Preece M.A., Cox L, Brook CD. Growth hormone increases rate of pubertal maturation. Acta Endocrinol. (Copenh.) 122: 414, 1990.Google Scholar
  4. 4.
    Laron Z., Sarel R., Pertzelan A. Puberty in Laron type dwarfism. Eur. J. Pediatr. 134: 79, 1980.PubMedGoogle Scholar
  5. 5.
    Advis J.P., Smith-White S., Ojeda S.R. Activation of growth hormone short loop negative feedback delays puberty in the female rat. Endocrinology 108: 1343, 1981.PubMedGoogle Scholar
  6. 6.
    Menashe Y., Sack J., Mashiach S. Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation? Hum. Reprod. 6: 670, 1991.PubMedGoogle Scholar
  7. 7.
    Moretti C, Fabbri A., Gnessi L, Bonifacio V., Bolotti M., Arizzi M., Nazzicone Q., Spera G. Immunohistochemical localization of growth hormone releasing hormone in human gonads. J. Endocrinol. Invest. 13: 301, 1990.PubMedGoogle Scholar
  8. 8.
    Moretti C, Bagnato A., Solan N., Frajese G., Catt K.J. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation. Endocrinology 127: 2117, 1990.PubMedGoogle Scholar
  9. 9.
    Bagnato A., Moretti C, Frajese G., Catt K.J. Gonadotropin-induced expression of receptors for growth hormone releasing factor in cultured granulosa cells. Endocrinology 128: 2889, 1991.PubMedGoogle Scholar
  10. 10.
    Katz E., Ricciarelli E., Adashi E.Y. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil. Steril. 59: 8, 1993.PubMedGoogle Scholar
  11. 11.
    Doldi N., Bassan M., Bonzi V., Ferrari A. Effects of growth hormone and growth hormone-releasing hormone on steroid synthesis in cultured human luteinizing granulosa cells. Gynecol. Endocrinol. 10: 101, 1996.PubMedGoogle Scholar
  12. 12.
    Nakajin S., Shinoda M., Hall P.F. C21 steroid side chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17-hydroxylase/C17.20-lyase cytochrome P450. J. Biol. Chem. 259: 3971, 1984.PubMedGoogle Scholar
  13. 13.
    Spicer L.J., Langhout D.J., Alpizar E., Williams S.K., Campbell R.M., Mowles T.F., Enright W.J. Effects of growth hormone-releasing factor and vasoactive intestinal peptide on proliferation and steroidogenesis of bovine granulosa cells. Mol. Cell. Endocrinol. 83: 73, 1992.PubMedGoogle Scholar
  14. 14.
    Arán B., Calderón G., Moragas M., Torelló M.J., Veiga A., Barri P.N. Chromosome anomalies in mouse zygotes treated by growth hormone-releasing factor. Hum. Reprod. 7: 1394, 1992.PubMedGoogle Scholar
  15. 15.
    Kaganowicz A., Farkouh N.H., Frantz A.G., Blaustein A.U. Ectopic human growth hormone in ovaries and breast cancer. J. Clin. Endocrinol. Metab. 48: 5, 1979.PubMedGoogle Scholar
  16. 16.
    Davies T.F., Katikineni M., Chan V., Harwood J.P.. Dufau M.L., Catt K.J. Lactogenic receptor regulation in hormone-stimulated steroidogenic cells. Nature 283: 863, 1980.PubMedGoogle Scholar
  17. 17.
    Ranke M.B., Stanley C.A., Tenore A., Rodbard D., Bongiovanni A.M., Parks J.S. Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes. Endocrinology 99: 1033, 1976.PubMedGoogle Scholar
  18. 18.
    Lobie P.E., Breipohl W., Aragon J.G., Waters M.J. Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems. Endocrinology 126: 2214, 1990.PubMedGoogle Scholar
  19. 19.
    Lobie P.E., Garcia-Aragon J., Wang B.S., Baumbach W.R., Waters M.J. Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130: 3057, 1992.PubMedGoogle Scholar
  20. 20.
    Jia X.-C, Kalmijn J., Hsueh A.J.W. Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology 118: 1401, 1986.PubMedGoogle Scholar
  21. 21.
    Hsu C.-J., Hammond J.M. Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells. Endocrinology 121: 1343, 1987.PubMedGoogle Scholar
  22. 22.
    Mason H.D., Martikainen H., Beard R.W., Anyaoku V., Franks S. Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells. J. Endocrinol. 126: R1–R4, 1990.PubMedGoogle Scholar
  23. 23.
    Barreca A., Minuto F., Volpe A., Cecchelli E., Cella F., Del Monte P., Artini P., Giordano G. Insulin-like growth factor-l (IGF-I) and IGF-I binding protein in the follicular fluids of growth hormone treated patients. Clin. Endocrinol. (Oxf.) 32: 497, 1990.Google Scholar
  24. 24.
    Barreca A., Artini P.G., Del Monte P., Ponzani P., Pasquini P., Cariola G., Volpe A., Genazzani A.R., Giordano G., Minuto F. In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J. Clin. Endocrinol. Metab. 77: 61, 1993.PubMedGoogle Scholar
  25. 25.
    El-Roeiy A., Chen X., Roberts V.J., Shimasaki S., Ling N., LeRoith D., Roberts C.T. jr., Yen S.S.C Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins 1–6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J. Clin. Endocrinol. Metab. 78: 1488, 1994.PubMedGoogle Scholar
  26. 26.
    Lanzone A., Di Simone N., Castellani R., Fulghesu A.M., Caruso A., Mancuso S. Human growth hormone enhances progesterone production by human luteal cells in vitro: evidence of a synergistic effect with human chorionic gonadotropin. Fertil. Steril. 57: 92,1992.PubMedGoogle Scholar
  27. 27.
    Hernandez E.R., Roberts CT., Hurwitz A., LeRoith D., Adashi E.Y. Rat ovarian insulin-like growth factor II gene expression is theca-interstitial cell-exclusive: hormonal regulation and receptor distribution. Endocrinology 127: 3249, 1990.PubMedGoogle Scholar
  28. 28.
    Geisthovel F., Moretti-Rojas I., Asch R.H., Rojas F.J. Expression insulin-like growth factor-ll (IGF-II) messenger ribonucleic acid (mRNA), but not IGF-I mRNA, in human preovulatory granulosa cells. Hum. Reprod. 4: 899, 1989.PubMedGoogle Scholar
  29. 29.
    Poretsky L, Kalin M.F. The gonadotropic function of insulin. Endocr. Rev. 8: 132, 1987.PubMedGoogle Scholar
  30. 30.
    Erickson G.F., Garzo V.G., Magoffin D.A. Insulin-like growth factor-l regulates aromatase activity in human granulosa and granulosa luteal cells. J. Clin. Endocrinol. Metab. 69: 716, 1989.PubMedGoogle Scholar
  31. 31.
    Christman G.M., Halme J.K. Growth hormone: revisited. Fertil. Steril. 57: 12, 1992.PubMedGoogle Scholar
  32. 32.
    Bergh C, Olsson J.-H., Hillensjö T. Effect of insulin-like growth factor I on steroidogenesis in cultured human granulosa cells. Acta Endocrinol. (Copenh.) 125: 177, 1991.Google Scholar
  33. 33.
    Adashi E.Y., Resnick CE., D’Ercole A.J., Svoboda M.E., Van Wyk J.J. Insulin-like growth factors as ovarian regulators of granulosa cell growth and function. Endocr. Rev. 6: 400, 1985.PubMedGoogle Scholar
  34. 34.
    Zapf J., Rinderknecht E., Humbel R.E., Froesch E.R. Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. Metabolism 27: 1803, 1978.PubMedGoogle Scholar
  35. 35.
    Phillips L.S., Vassilopoulou-Sellin R. Somatomedins. N. Engl. J. Med. 302: 371, 1980.PubMedGoogle Scholar
  36. 36.
    Davoren J.B., Hsueh A.J.W. Growth hormone increases ovarian levels of immunoreactive somatomedin C/insulin-like growth factor I in vivo. Endocrinology 118: 888, 1986.PubMedGoogle Scholar
  37. 37.
    Homburg R., West C, Torresani T., Jacobs H.S. Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial. Fertil. Steril. 53: 254, 1990.PubMedGoogle Scholar
  38. 38.
    Owen E.J., Torresani T., West C, Mason B.A., Jacobs H.S. Serum and follicular fluid insulin like growth factors I and II during growth hormone cotreatment for invitro fertilization and embryo transfer. Clin. Endocrinol. (Oxf.) 35: 327, 1991.Google Scholar
  39. 39.
    Davoren J.B., Hsueh A.J.W., Li CH. Somatomedin C augments FSH-induced differentiation of cultured rat granulosa cells. Am. J. Physiol. 249: E26, 1985.PubMedGoogle Scholar
  40. 40.
    Blumenfeld Z. Growth hormone—A cogonadotropin? Its role in ovulation induction. J. In Vitro Fert. Embryo Transfer 8: 127, 1991.Google Scholar
  41. 41.
    Balboni G.C, Vannelli G.B., Barni T., Orlando C, Serio M. Transferrin and somatomedin C receptors in the human ovarian follicles. Fertil. Steril. 48: 706, 1987.Google Scholar
  42. 42.
    Gates G.S., Bayer S., Siebel M., Poretsky L, Flier J.S., Moses A.C. Characterization of insulin-like growth factor binding to human granulosa cells obtained during in-vitro fertilization. J. Recept. Res. 7: 885, 1987.PubMedGoogle Scholar
  43. 43.
    Hsu C.-J., Hammond J.M. Gonadotropin and estradiol stimulate immunoreactive insulin-like growth factor-l production by porcine granulosa cells in vitro. Endocrinology 120: 198, 1987.PubMedGoogle Scholar
  44. 44.
    Mondschein J.S., Hammond J.M. Growth factors regulate immunoreactive insulin-like growth factor-l production by cultured porcine granulosa cells. Endocrinology 123: 463, 1988.PubMedGoogle Scholar
  45. 45.
    Apa R., Di Simone N., Ronsisvalle E., Miceli F., de Feo D., Caruso A., Lanzone A., Mancuso S. Insulin-like growth factor (IGF)-I and IGF-II stimulate progesterone production by human luteal cells: role of IGF-I as mediator of growth hormone action. Fertil. Steril. 66: 235, 1996.PubMedGoogle Scholar
  46. 46.
    Mondschein J.S., Canning S.F., Miller D.Q., Hammond J.M. Insulin-like growth factors (IGFs) as autocrine/paracrine regulators of granulosa cell differentiation and growth: studies with a neutralizing monoclonal antibody to IGF-I. Biol. Reprod. 47: 79, 1989.Google Scholar
  47. 47.
    Voutilainen R., Miller W.L. Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain cleavage enzyme, P-450ssc, in human steroidogenic tissue. Proc. Natl. Acad. Sei. USA 84: 1590, 1987.Google Scholar
  48. 48.
    Ramasharma K., Li CH. Human pituitary and placental hormone control of human insulin-like growth factor II secretion in human granulosa cells. Proc. Natl. Acad. Sei. USA 84: 2643, 1987.Google Scholar
  49. 49.
    Ramasharma K., Cabrera CM., Li CH. Identification of insulin-like growth factor-ll in human seminal and follicular fluids. Biochem. Biophys. Res. Commun. 140: 536, 1986.PubMedGoogle Scholar
  50. 50.
    Friedman A.J., Rein M.S., Pandian M.R., Barbieri R.L. Fasting serum growth hormone insulin-like growth factor-l and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo. Fertil. Steril. 53: 250, 1990.PubMedGoogle Scholar
  51. 51.
    Carlsson B., Bergh C, Bentham J., Olsson J.-H., Norman M.R., Billig H., Roos P., Hillensjö T. Expression of functional growth hormone receptors in human granulosa cells. Hum. Reprod. 7: 1205, 1992.PubMedGoogle Scholar
  52. 52.
    Ovesen P., Ingerslev H.J., Ørskov H., Ledet T. Effect of growth hormone on steroidogenesis, insulin-like growth factor-l (IGF-I) and IGF binding protein-1 production and DNA synthesis in cultured human luteinized granulosa cells. J. Endocrinol. 140: 313, 1994.PubMedGoogle Scholar
  53. 53.
    Fowler P.A., Templeton A. Ovarian response to gonadotrophins: effects of growth hormone. Clin. Endocrinol. (Oxf.) 35: 117, 1991.Google Scholar
  54. 54.
    Jacobs H.S., Bouchard P., Conway G.S., Homburg R., Lahlou N., Mason B., Ostergaard H., Owen E.J. Role of growth hormone in infertility. Horm. Res. 36 (suppl. 1): 61, 1991.PubMedGoogle Scholar
  55. 55.
    Shoham Z., Homburg R., Owen E.J., Conway G.S., Ostergaard H., Jacobs H.S. The role of treatment with growth hormone in infertile patients. Baillieres Clin. Obstet. Gynaecol. 6: 267, 1992.PubMedGoogle Scholar
  56. 56.
    Meirow D., Laufer N., Schenker J.G. Ovulation induction in in vitro fertilization. Gynecol. Endocrinol. 6: 211, 1992.PubMedGoogle Scholar
  57. 57.
    Jacobs H.S. Growth hormone and ovulation: is there an indication for treatment of infertile women with growth hormone? Horm. Res. 38 (suppl. 1): 14, 1992.PubMedGoogle Scholar
  58. 58.
    Homburg R. Ovulation induction in gonadotrophin-resistant women. Baillieres Clin. Obstet. Gynaecol. 7: 349, 1993.PubMedGoogle Scholar
  59. 59.
    Katz E. The use of growth hormone treatment for ovulation induction. Curr. Opin. Obstet. Gynecol. 5:234, 1993.PubMedGoogle Scholar
  60. 60.
    Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 14: 20, 1993.PubMedGoogle Scholar
  61. 61.
    Meirow D., Laufer N., Schenker J.G. Ovulation induction in polycystic ovary syndrome: a review of conservative and new treatment modalities. Eur. J. Obstet. Gynecol. Reprod. Biol. 50: 123, 1993.PubMedGoogle Scholar
  62. 62.
    Levron J., Lewit N., Erlik Y., Itskovitz-Eldor J. No beneficial effects of human growth hormone therapy in normal ovulatory patients with a poor ovarian response to gonadotropins. Gynecol. Obstet. Invest. 35: 65, 1993.PubMedGoogle Scholar
  63. 63.
    Lippe B.M., Nakamoto J.M. Conventional and nonconventional uses of growth hormone. Recent Prog. Horm. Res. 48: 179, 1993.PubMedGoogle Scholar
  64. 64.
    Blumenfeld Z., Amit T. The role of growth hormone in ovulation induction. Ann. Med. 26: 249, 1994.PubMedGoogle Scholar
  65. 65.
    Ben-Rafael Z., Orvieto R., Feldberg D. The poor-responder patient in an in vitro fertilization—embryo transfer (IVF-ET) program. Gynecol. Endocrinol. 8: 277, 1994.PubMedGoogle Scholar
  66. 66.
    Homburg R., Ostergaard H. Clinical applications of growth hormone for ovarian stimulation. Hum. Reprod. Update 1: 26, 1995.Google Scholar
  67. 67.
    Homburg R., Ben-Rafael Z. The place of cotreatment with growth hormone and human menopausal gonadotropin (hMG) in ovarian stimulation. J. Assist. Reprod. Genet. 13: 371, 1996.PubMedGoogle Scholar
  68. 68.
    Homburg R. Growth hormone and fertility - Clinical studies. Horm. Res. 45: 81, 1996.PubMedGoogle Scholar
  69. 69.
    Blumenfeld Z, Lunenfeld B. The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotropin in a panhypopituitary patient. Fertil. Steril. 52: 328, 1989.PubMedGoogle Scholar
  70. 70.
    Ibrahim Z.H.Z., Matson P.L., Buck P., Lieberman B.A. The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response. Fertil. Steril. 55: 202, 1991.PubMedGoogle Scholar
  71. 71.
    Owen E.J., Shoham Z., Mason B.A., Ostergaard H., Jacobs H.S. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil. Steril. 56: 1104, 1991.PubMedGoogle Scholar
  72. 72.
    European and Australian Multicenter Study. Cotreatment with growth hormone and gonadotropin for ovulation induction in hypogonadotropic patients: a prospective, randomized, placebo-controlled, dose-response study. Fertil. Steril. 64: 917, 1995.Google Scholar
  73. 73.
    Volpe A., Coukos G., Barreca A., Artini P.G., Minuto F., Giordano G., Genazzani A.R. Ovarian response to combined growth hormone—gonadotropin treatment in patients resistant to induction of superovulation. Gynecol. Endocrinol. 3: 125, 1989.PubMedGoogle Scholar
  74. 74.
    Hughes S.M., Huang Z.H., Morris I.D., Matson P.L., Buck P., Lieberman B.A. A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responded to in-vitro fertilization. Hum. Reprod. 9: 13, 1994.PubMedGoogle Scholar
  75. 75.
    Bergh C, Hillensjö T., Wikland M., Nilsson L., Borg G., Hamberger L. Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertil. Steril. 62: 113, 1994.PubMedGoogle Scholar
  76. 76.
    Dor J., Seidman D.S., Amudai E., Bider D., Levran D., Mashiach S. Adjuvant growth hormone therapy in poor responded to in-vitro fertilization: a prospective, randomized, placebo-controlled, double-blind study. Hum. Reprod. 10: 40, 1995.PubMedGoogle Scholar
  77. 77.
    Shaker A.G., Fleming R., Jamieson M.E., Yates R.W.S., Coutts J.R.T. Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responded. Fertil. Steril. 58: 919, 1992.PubMedGoogle Scholar
  78. 78.
    Levy T., Limor R., Villa Y., Eshel A., Eckstein N., Vagman I., Lidor A., Ayalon D. Another look at cotreatment with growth hormone and human menopausal gonadotrophins in poor ovarian responders. Hum. Reprod. 8: 834, 1993.PubMedGoogle Scholar
  79. 79.
    Owen E.J., West C, Mason B.A., Jacobs H.S. Cotreatment with growth hormone of sub-optimal responders in IVF-ET. Hum. Reprod. 6:524, 1991.PubMedGoogle Scholar
  80. 80.
    Hugues J.-N., Torresani T., Herve F., Martin-Pont B., Tamboise A., Santarelli J. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women. Fertil. Steril. 55: 945, 1991.PubMedGoogle Scholar
  81. 81.
    Garcia J.E., Jones G.S., Acosta A.A., Wright G. jr. Human menopausal gonadotropin human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II. Fertil. Steril. 39: 174, 1983.PubMedGoogle Scholar
  82. 82.
    Ben-Rafael Z., Feldberg D. The poor-responder patient in an in vitro fertilization-embryo transfer program. J. Assist. Reprod. Genet. 10: 118, 1993.PubMedGoogle Scholar
  83. 83.
    Cassar J., Verco CG., Joplin G.F. Successful pregnancy induced by human menopausal gonadotropin in a patient with growth hormone deficiency and primary amenorrhea: a case report. Br. J. Obstet. Gynaecol. 87: 337, 1980.PubMedGoogle Scholar
  84. 84.
    Dawood M.Y., Jarrett J.C., Choe J.K. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins. Fertil. Steril. 38: 415, 1982.PubMedGoogle Scholar
  85. 85.
    Homburg R., Eshel A., Abdalla HJ., Jacobs H.S. Growth hormone facilitates ovulation induction by gonadotrophins. Clin. Endocrinol. 29: 113, 1988.Google Scholar
  86. 86.
    Homburg R., West C, Torresani T., Jacobs H.S. A comparative study of single-dose growth hormone therapy as an adjuvant to gonadotropin treatment for ovulation induction. Clin. Endocrinol. 32: 781, 1990.Google Scholar
  87. 87.
    Burger H.G., Kovacs G.T., Poison D.M., McDonald J., McCloud P.I., Harrop M., Colman P., Healy D.L. Ovarian sensitization to gonadotrophins by human growth hormone. Persistence of the effect beyond the treated cycle. Clin. Endocrinol. (Oxf.) 35: 119, 1991.Google Scholar
  88. 88.
    Homburg R., West C, Ostergaard H., Jacobs H.S. Combined growth hormone and gonadotropin treatment for ovulation induction in patients with non-responsive ovaries. Gynecol. Endocrinol. 5: 33, 1991.PubMedGoogle Scholar
  89. 89.
    Volpe A., Coukos G., Artini P.G., Silferi M., Petraglia F., Boghen M., D’Ambrogio G., Genazzani A.R. Pregnancy following combined growth hormone-pulsatile GnRH treatment in a patient with hypothalamic amenorrhea. Hum. Reprod. 5: 345, 1990.PubMedGoogle Scholar
  90. 90.
    Adams J., Franks S., Poison D.W., Mason H.D., Abdulwahid N., Tucker M., Morris D.V., Price J., Jacobs H.S. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2: 1375, 1985.PubMedGoogle Scholar
  91. 91.
    Volpe A., Artini P.G., Barreca A., Minuto F., Coukos G., Genazzani A.R. Effects of growth hormone administration in addition to gonadotrophins in normally ovulating women and polycystic ovary syndrome (PCO) patients. Hum. Reprod. 7: 1347, 1992.PubMedGoogle Scholar
  92. 92.
    Homburg R., Levy T., Ben-Rafael Z. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial. Hum. Reprod. 10: 2550, 1995.PubMedGoogle Scholar
  93. 93.
    Quigley M., Rakoff J.S., Yen S.S.C. Increased luteinizing hormone. Sensitivity to dopamine inhibition in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 52: 231, 1981.PubMedGoogle Scholar
  94. 94.
    Shoupe D., Lobo R. Evidence for an altered cathecolamine metabolism in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 150: 566, 1984.PubMedGoogle Scholar
  95. 95.
    Cumming D.C, Reid R.L., Quigley M. Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 20: 643, 1984.Google Scholar
  96. 96.
    Wortsman J., Wehrenberg W.B., Gavin III J.R., Allen J.P. Elevated levels of β-endorphin and γ3-melanocyte stimulating hormone in the polycystic ovarian syndrome. Obstet. Gynecol. 63: 630, 1984.PubMedGoogle Scholar
  97. 97.
    Anaplitou L.G., Syrygos K., Panayotakopoulos G., Kalos A., Batrinos M.L. Paradoxical growth hormone response following thyroid-stimulating hormone administration in the polycystic ovarian syndrome. Horm. Res. 31: 119, 1989.Google Scholar
  98. 98.
    Chang R.J., Nakamura R.M., Judd H.L., Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 57: 356, 1983.PubMedGoogle Scholar
  99. 99.
    Lanzone A., Fulghesu A.M., Pappalardo S., Proto C, Le Donne M., Andreani C.L., Muscatello R., Caruso A., Mancuso S. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism. Gynecol. Obstet. Invest. 29: 149, 1990.PubMedGoogle Scholar
  100. 100.
    Burghen G.A., Givens J.R., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50: 113, 1980.PubMedGoogle Scholar
  101. 101.
    Urdl W. Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C. Arch. Gynecol. Obstet. 243: 13, 1988.PubMedGoogle Scholar
  102. 102.
    Artini P.G., Battaglia C, D’Ambrogio G., Barreca A., Droghini F., Volpe A., Genazzani A.R. Relationship between human oocyte maturity, fertilization and follicular fluid growth factors. Hum. Reprod. 9: 902, 1994.PubMedGoogle Scholar
  103. 103.
    Hughes S.M., Huang Z.H., Matson P.L., Buck P., Lieberman B.A., Morris I.D. Clinical and endocrinological changes in women following ovulation induction using buserelin/acetate human menopausal gonadotrophin augmented with biosynthetic human growth hormone. Hum. Reprod. 7: 770, 1992.PubMedGoogle Scholar
  104. 104.
    Younis J.S., Simon A., Koren R., Dorembus D., Schenker J.G., Laufer N. The effect of growth hormone supplementation on in-vitro fertilization outcome: a prospective randomized placebo controlled double-blind study. Fertil. Steril. 58: 575, 1992.PubMedGoogle Scholar
  105. 105.
    Tapanainen J., Martikainen H., Voutilainen R., Orava M., Ruokonen A., Rönnberg L. Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertil. Steril. 58: 726, 1992.PubMedGoogle Scholar
  106. 106.
    Tzeng CR., Chien L.W., Cheng Y.F., Chang S.R., Chen A.C. Enhancement of IVF pregnancy rates by cotreatment with low dose growth hormone. J. Assist. Reprod. Genet. 10 (Suppl): 111, 1993.Google Scholar
  107. 107.
    Volpe A., Coukos G., Barreca A., Giordano G.. Artini P.G., Genazzani A.R. Clinical use of growth hormone-releasing factor for induction of superovulation. Hum. Reprod. 6: 1228, 1991.PubMedGoogle Scholar
  108. 108.
    Tulandi T., Falcone T., Guyda H., Hemmings R., Billiar R., Morris D. Effect of synthetic growth hormone-releasing factor in women treated with gonadotrophin. Hum. Reprod. 8: 525, 1993.PubMedGoogle Scholar
  109. 109.
    Genazzani A.R., Artini P.G., Battaglia C, Droghini F., Mancini A.C., D’Ambrogio G. Clinical effects of GRF plus pFSH in poor-responder patients. In: Andreoli M., Shields M. (Eds.), Highlignts in molecular and clinical endocrinology, Frontiers in Endocrinology. Ares-Serono Symposia Publications, Rome, 1994, vol. 9, p. 249.Google Scholar
  110. 110.
    Jørgensen J.O. Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr. Rev. 12: 189, 1991.PubMedGoogle Scholar
  111. 111.
    Blumenfeld Z., Dirnfeld M., Gonen Y., Abramovici H. Growth hormone cotreatment for ovulation induction may enhance conception in the cotreatment and succeeding cycles, in clonidine negative but not clonidine positive patients. Hum. Reprod. 9: 209, 1994.PubMedGoogle Scholar
  112. 112.
    Ituarte E.A., Petrini J., Hershman J.M. Acromegaly and colon cancer. Ann. Intern. Med. 101: 627, 1984.PubMedGoogle Scholar
  113. 113.
    Ogilvy-Stuart A.L., Shalet S.M. Tumour occurrence and recurrence. Horm. Res. 38 (suppl. 1): 50, 1992.PubMedGoogle Scholar
  114. 114.
    Parker M.L., Hammond J.M., Daughaday W.H. The arginine provocative test: an aid in the diagnosis of hyposomatotropism. J. Clin. Endocrinol. Metab. 27: 1129, 1967.PubMedGoogle Scholar
  115. 115.
    Ghigo E., Goffi S., Nicolosi M., Arvat E., Valente F., Mazza E., Ghigo M.C, Camanni F. Growth hormone (GH) responsiveness to combined administration of arginine and GH-reieasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab. 71: 1481, 1990.PubMedGoogle Scholar
  116. 116.
    Davis T.M.E., Burrin J.M., Bloom S.R. Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. J. Clin. Endocrinol. Metab. 65: 1248, 1987.PubMedGoogle Scholar
  117. 117.
    Fass B., Lippe B.M., Kaplan S.A. Relative usefulness of three growth hormone stimulation screening tests. Am. J. Dis. Child. 133: 931, 1979.PubMedGoogle Scholar
  118. 118.
    Shibasaki T., Hotta M., Masuda A., Imaki T., Obara N., Demura H., Ling N., Shizume K. Plasma GH response to GRH and insulin induced hypoglycemia in man. J. Clin. Endocrinol. Metab. 60: 1265, 1985.PubMedGoogle Scholar
  119. 119.
    Lancranjan I., Marbach P. New evidence for growth hormone modulation by alpha-adrenergic system in man. Metabolism 26: 1225, 1977.PubMedGoogle Scholar
  120. 120.
    Slover R.H., Klingensmith G.J., Gotlin R.W., Radcliffe J. A comparison of Clonidine and standard provocative agents of growth hormone. Am. J. Dis. Child. 138: 314, 1984.PubMedGoogle Scholar
  121. 121.
    Frasier S.D. A review of growth hormone stimulation tests in children. Pediatrics 53: 929, 1974.PubMedGoogle Scholar
  122. 122.
    Moll G.W. jr., Rosenfield R.L., Fang V.S. Administration of low-dose estrogen rapidly and directly stimulates growth hormone production. Am. J. Dis. Child. 140: 124, 1986.PubMedGoogle Scholar
  123. 123.
    Arends J., Wagner W.-L, Willms B.L. Cholinergic muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in type I diabetic subjects. J. Clin. Endocrinol. Metab. 66: 389, 1988.PubMedGoogle Scholar
  124. 124.
    Alba-Roth J., Müller O.A., Schopohl J., von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.PubMedGoogle Scholar
  125. 125.
    Menashe Y., Lunenfeld B., Pariente C, Frenkel Y., Mashiach S. Can growth hormone increase, after Clonidine administration, predict the dose of human menopausal hormone needed for induction of ovulation? Fertil. Steril. 53: 432, 1990.PubMedGoogle Scholar
  126. 126.
    Ovesen P., Møller J., Møller N., Christiansen J.S., Ørskov H., Jørgensen J.O.L. Growth hormone secretory capacity and serum insulin-like growth factor I levels in primary infertile, anovulatory women with regular menses. Fertil. Steril. 57: 97, 1992.PubMedGoogle Scholar
  127. 127.
    Salat-Baroux J., Rotten D., Alvarez S., Antoine J.M. Comparison of growth hormone responses to growth hormone-releasing factor and Clonidine in women with normal or poor ovarian response to gonadotropin stimulation. Fertil. Steril. 60: 791, 1993.PubMedGoogle Scholar
  128. 128.
    Stone B.A., Marrs R.P. Ovarian response to menopausal gonadotropins in groups of patients with differing basal growth hormone levels. Fertil. Steril. 58: 32, 1992.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1996

Authors and Affiliations

  • P. G. Artini
    • 1
  • A. A. de Micheroux
    • 1
  • G. D’Ambrogio
    • 1
  1. 1.Centra di Procreazione Assistita, Istituto di Clinica Ostetrica e Ginecologica “Piero Fioretti”University of PisaPisaItaly

Personalised recommendations